连续性肾脏替代治疗启动时机与脓毒症相关急性肾损伤患者预后的关系
该回顾性研究纳入244例ICU内接受CRRT的SA-AKI患者,按KDIGO分期将1-2期启动CRRT者归为早期组(71例),3期启动者归为晚期组(173例)。早期组CRRT时长显著短于晚期组[26.0(12.0, 49.0)小时 vs. 41.0(20.8, 87.0)小时,P<0.01],但两组ICU住院时间、总住院时间、28天和90天死亡率、RRT脱离率及存活者RRT依赖率均无显著差异,90天累积生存率亦无差异(χ²=0.791,P=0.374)。结论提示早期启动CRRT仅缩短CRRT时长,对肾功能恢复和死亡率无影响,SA-AKI最佳CRRT启动时机仍不明确。
要点
- 早期组(KDIGO 1-2期启动CRRT)CRRT时长显著短于晚期组(KDIGO 3期启动)[26.0(12.0, 49.0)小时 vs. 41.0(20.8, 87.0)小时,P<0.01]。
- 早期组与晚期组28天死亡率(45.1% vs. 48.0%)、90天死亡率(46.4% vs. 51.4%)均无显著差异(P>0.05)。
- 两组28天RRT脱离率(49.3% vs. 45.1%)、90天RRT脱离率(52.1% vs. 47.4%)及存活者RRT依赖率均无显著差异(P>0.05)。
- Kaplan-Meier分析显示两组90天累积生存率无显著差异(Log-Rank χ²=0.791,P=0.374)。
- SA-AKI患者CRRT最佳启动时机目前仍未知,早期启动仅缩短CRRT时长,不改变ICU住院时间、总住院时间、肾功能恢复或死亡率。
适用人群与场景
- 按KDIGO分期,AKI 1期或2期启动CRRT者纳入早期治疗组(71例),AKI 3期启动CRRT者纳入晚期治疗组(173例)。
诊断标准与关键阈值
- 采用KDIGO指南对AKI进行分期,AKI 1期或2期启动CRRT定义为早期治疗,AKI 3期启动CRRT定义为晚期治疗。
- 原文未提及具体的启动/停止阈值或评分界值。
处置流程与药物剂量
- 原文未提及具体的CRRT处方剂量、置换液流速、抗凝方案细节或目标值。
- 原文未提及CRRT启动或停止的具体流程步骤。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:单中心回顾性分析,样本量244例(早期组71例,晚期组173例),无多中心数据。
- 人群:ICU内接受CRRT的SA-AKI患者;两组年龄、性别、APACHE II评分、手术患者比例、感染部位及抗凝方案无显著差异。
- 干预与对照:早期组(KDIGO 1-2期启动CRRT)vs. 晚期组(KDIGO 3期启动CRRT)。
- 主要终点结果:早期组CRRT时长显著短于晚期组[26.0(12.0, 49.0)小时 vs. 41.0(20.8, 87.0)小时,P<0.01]。
- 关键次要终点:ICU住院时间[9.0(4.0, 15.0)天 vs. 10.0(4.5, 18.0)天]、总住院时间[17.0(10.0, 30.0)天 vs. 18.0(10.0, 32.0)天]、28天死亡率(45.1% vs. 48.0%)、90天死亡率(46.4% vs. 51.4%)、28天RRT脱离率(49.3% vs. 45.1%)、90天RRT脱离率(52.1% vs. 47.4%)均无显著差异(均P>0.05)。
- 存活者28天RRT依赖率[10.3%(4/39) vs. 13.3%(12/90)]和90天RRT依赖率[2.6%(1/38) vs. 2.4%(2/84)]无显著差异(均P>0.05)。
- Kaplan-Meier生存分析:两组90天累积生存率无显著差异(Log-Rank χ²=0.791,P=0.374)。
- 不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:单中心、回顾性设计、样本量有限(244例),早期组与晚期组样本量不均衡(71 vs. 173),可能存在选择偏倚和混杂因素;原文未提及盲法或混杂校正方法。
对床旁实践的改变
- 对于SA-AKI患者,早期(KDIGO 1-2期)启动CRRT可缩短CRRT治疗时长,但不应期望借此缩短ICU住院时间、总住院时间或改善肾功能恢复及死亡率。
- SA-AKI患者CRRT最佳启动时机仍不明确,临床决策不能仅依据KDIGO分期早晚来判断是否启动CRRT。
- 该研究为单中心回顾性分析,结果需前瞻性研究验证,不能作为改变临床实践的唯一依据。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the relationship between the timing of initiation of continuous renal replacement therapy (CRRT) and the prognosis of patients with sepsis associated-acute kidney injury (SA-AKI).
METHODS: The clinical data of SA-AKI patients undergoing CRRT in intensive care unit (ICU) of Ningbo First Hospital from January 2017 to November 2019 were retrospectively analyzed. According to the guidelines for Kidney Disease: Improving Global Outcomes (KDIGO), patients with AKI who started CRRT in stage 1 or 2 were included in the early treatment group, and those started CRRT in stage 3 were included in the late treatment group. The general clinical data, length of ICU stay, total length of hospital stay, 28-day and 90-day mortality, CRRT duration, 28-day and 90-day renal replacement therapy (RRT) disengagement rate, 28-day and 90-day RRT dependence rate in the survival patients were compared between the two groups. Kaplan-Meier survival analysis was performed to assess the 90-day cumulative survival rate of patients with SA-AKI between two groups.
RESULTS: A total of 244 SA-AKI patients were enrolled in this study, including 71 patients in the early treatment group and 173 patients in the late treatment group. There were no significant differences in age, gender composition, acute physiology and chronic health evaluation II (APACHE II), proportion of surgical patients, infection site and anticoagulation program between the two groups. The CRRT duration in the early group was significantly shorter than that in the late group [hours: 26.0 (12.0, 49.0) vs. 41.0 (20.8, 87.0), P < 0.01], but there were no significant differences in the length of ICU stay [days: 9.0 (4.0, 15.0) vs. 10.0 (4.5, 18.0)], total length of hospital stay [days: 17.0 (10.0, 30.0) vs. 18.0 (10.0, 32.0)], 28-day mortality (45.1% vs. 48.0%), 90-day mortality (46.4% vs. 51.4%), 28-day RRT disengagement rate (49.3% vs. 45.1%) and 90-day RRT disengagement rate (52.1% vs. 47.4%) between the early treatment group and late treatment group (all P > 0.05). There were also no significant differences in 28-day RRT dependence rate [10.3% (4/39) vs. 13.3% (12/90)] and 90-day RRT dependence rate [2.6% (1/38) vs. 2.4% (2/84)] between early treatment group and late treatment group (both P > 0.05). Kaplan-Meier survival analysis suggested that there was no significant difference in the 90-day cumulative survival rate between two groups (Log-Rank test: χ2 = 0.791, P = 0.374).
CONCLUSIONS: Early initiation of CRRT treatment in SA-AKI patients can reduce the duration of CRRT, but has no effect on length of ICU stay, total length of hospital stay, renal function recovery and mortality. At present, the optimal timing for initiation of CRRT in patients with SA-AKI remains unknown.
参考来源
- Wu X, Ye J, Sun M, et al. [Relationship between the timing of initiation of continuous renal replacement therapy and the prognosis of patients with sepsis-associated acute kidney injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33463496. doi:10.3760/cma.j.cn121430-20200304-00206
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。